Abstract:Purpose: To investigate the relationship of (lymph) angiogenesis and survival time of human cornea grafts.Methods: This was a case series study. A total of 250 patients requiring a second keratoplasty were screened according to our inclusion criteria: 1) only cases with primary non-inflamed cornea diseases were included; and 2) all primary diseased cornea specimens from the first corneal transplantation were confirmed not to have hemangiogenesis or lymphangiogenesis. The included patients were analyzed retrospectively and followed up for the survival time of the first and second grafts. Blood vessel content (BVC) and lymphatic vessel content (LVC) were assessed in the primary diseased cornea; first rejected grafts (including BVC1 and LVC1) and second rejected grafts (including BVC2 and LVC2) were assessed by immunohistochemistry. The survival times of the first (STG(1)) and second (STG(2)) rejected corneal grafts were calculated and the relationship between human corneal (lymph) angiogenesis and STG was statistically analyzed.Results: After screening, only 23 patients (23 eyes) were included. Their primary cornea diseases were non-inflamed, including keratoconus (n=14), leukoma (n=5), and Fuchs endothelial dystrophy (n=4). The mean duration of follow up was 36 months after the second keratoplasty. In all, 55 cornea specimens from different times following penetrating keratoplasty were collected and examined, including 23 primary non-inflamed corneas (without angiogenesis), 23 first rejected corneal grafts (all with hemangiogenesis, but only six cases with blown lymphatic vessels), and nine rejected corneal grafts (including six cases identified with lymphangiogenesis in the first rejection, all with lymphangiogenesis and hemangiogenesis). Based on our statistical analysis, STG(1) was correlated with LVC1 but not with BVC1 or (LVC1+BVC1), while STG(2) was correlated with (LVC1+LVC2), LVC1, LVC2, (LVC2+BVC2) and (LVC1+BVC1) but not with BVC1 or BVC2.Conclusions: The survival time of human cornea grafts is related to both lymphangiogenesis and hemangiogenesis. Lymphangiogenesis only occurred in some rejected cases, but it seems to be a signal of poor prognosis for the new allograft.

Research progress on the correlation between corneal neovascularization and lymphangiogenesis (Review)

Recent Advance on Pathogenesis of Choroidal Neovascularization

Progress on mechanism and therapeutic of corneal neovascularization

Review of the Progress in Corneal Neovascularization Animal Models

Progress on the establishment of corneal neovascularization animal model

Research Progress in Corneal Neovascularization and Microenvironment

Clinical research of corneal lymphangiogenesis after corneal transplantation

Angiogenesis and lymphangiogenesis in corneal transplantation–A review

Recent Advances in Corneal Neovascularization Imaging

New targets of nascent lymphatic vessels in ocular diseases

Progress in Research on the Role of FGF in the Formation and Treatment of Corneal Neovascularization

Management of corneal neovascularization: Current and emerging therapeutic approaches

Clinical and Experimental Research of Corneal Lymphangiogenesis after Keratoplasty.

Restoration of corneal epithelial barrier function: a possible target for corneal neovascularization

Corneal neovascularization and treatment

Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis

An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization

Clinicopathological Correlation Analysis of (lymph) Angiogenesis and Corneal Graft Rejection

Research Progress on Conjunctival Lymphatic Vessels

Corneal Lymphangiogenesis Correlates Closely With Hemangiogenesis After Keratoplasty

Identification of Corneal Neovascularization–Related Long Noncoding RNAs Through Microarray Analysis